Patient Identification
Collect full legal name, date of birth, preferred name, and contact details to ensure correct matching with records and to reduce duplication across care systems.
A standardized Healthcare Harm Reduction Form clarifies patient preferences, documents informed consent, and creates a retrievable record that supports clinical decisions and reporting. Where the record contains protected health information it must be treated under HIPAA and retained per applicable rules.
The Healthcare Harm Reduction Form is completed by clinical and outreach teams working directly with people who use drugs, and by administrative staff managing referrals and reporting.
Use the form as part of intake, care planning, follow-up, and when documenting consent or refusal for specific interventions.
The Clinic Director signs to confirm organizational policies and program-level consent processes. Their signature indicates institutional oversight for harm-reduction protocols and may be required for funding or program audits.
The Program Coordinator documents service delivery details, certifies staff-completed interventions, and signs attestation that referrals and follow-ups were offered according to program standards.
| Form Fields | Mark name, DOB, consent boxes, and signature fields as required. |
|---|---|
| Authentication | Use email verification, SMS codes, or stronger methods for identity assurance. |
| Conditional Logic | Show intervention sections only when the patient indicates relevant risk behaviors. |
| Templates | Create reusable templates for common clinic workflows to save time. |
| Notifications | Email or system notifications route completed forms to care coordinators. |
Ensure the platform you use supports secure storage, required authentication, and audit logging before enabling electronic completion.
Collect full legal name, date of birth, preferred name, and contact details to ensure correct matching with records and to reduce duplication across care systems.
Include structured questions about substance types, frequency, route, overdose history, and co-occurring conditions that directly inform recommended harm-reduction measures and safety planning.
Explain each intervention (e.g., naloxone distribution, syringe access), list benefits/risks, and capture dated signatures to document explicit consent or refusal for each service offered.
Specify items provided (supplies, education), goals, responsible staff, and expected follow-up intervals so the plan is actionable and auditable for quality reviews.
Document the referral recipient, appointment date/time if scheduled, contact person, and any warm-handoff notes to improve linkage outcomes and reduce missed connections.
Record follow-up attempts, outcomes, and reassessment dates to support continuity of care and to meet program reporting requirements for funders and oversight bodies.
Complete and sign during the encounter or within 24–48 hours.
Attempt warm handoff within 7 days when feasible.
Report any adverse events per local policy promptly.
Submit service aggregates per funder schedule.
Retain records per regulatory timelines and program rules.
Patient registration and risk screening completed at first contact.
Agree on interventions and obtain signatures during visit.
Provide supplies, education, or referrals as documented in the plan.
Document outcomes, repeat risk screening, and update plan as needed.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Varies by plan | Varies by plan | Varies by plan | Varies by plan |
| Bulk Send | Yes (Business Premium) | Yes | Yes | Yes | Yes |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes (BAA available) | Yes | Yes | Varies | Varies |